![](/img/cover-not-exists.png)
Beyond GLP-1: is GPCR poly-pharmacology the path forward to treating metabolic diseases?
Sloop, Kyle W., Briere, Daniel A, Emmerson, Paul J, Willard, Francis SLanguage:
english
Journal:
ACS Pharmacology & Translational Science
DOI:
10.1021/acsptsci.8b00009
Date:
June, 2018
File:
PDF, 491 KB
english, 2018